OTC · THCT
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 5:01 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · THCT
1M range · 5 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
THCT closed at $0.00 after 5 trading sessions, down 40.00% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 101 |
| Sep 29, 2026 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 1K |
| Sep 25, 2026 | $0.0007 | $0.0007 | $0.0007 | $0.0007 | 900 |
| Sep 21, 2026 | $0.0006 | $0.0006 | $0.0006 | $0.0006 | 600 |
| Sep 11, 2026 | $0.0005 | $0.0005 | $0.0005 | $0.0005 | 200 |
The latest Smart Investors Daily articles mentioning THCT.
Company
Market Activity
Research & News
THCT research
Company profile and research snapshot.
THC THERAPEUTICS INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Jul 9, 2025
THC Therapeutics has acquired SugarTop Buddery, a cannabis brand based in Eugene, Oregon, for approximately $3 million in an all-share transaction. The acquisition expands THCT's operations in Oregon and adds a respected craft cannabis company to its portfolio.
Benzinga · Jun 24, 2025
THC Therapeutics, Inc. has acquired The Headquarters Group, Inc., a holding company with a portfolio of cannabis-related businesses in genetics, cultivation, extraction, and distribution, as well as specialty real estate and nutrients. The combined company aims to leverage its expertise and resources to expand its operations in the regulated cannabis industry.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning THCT.
No results
No recent SID articles mention THCT.
